It is widely considered to be a driver of transcriptional activation and is involved in a variety of cancers by mediating the expression of oncogenes such as c-MYC, bcl-xL and bcl-6 (Lovén et al., 2013; Donati, Lorenzini, and Ciarrocchi 2018). The gene discussed is BCL2L1; the disease is cancer.